科研项目

1.广州实验室：疫情暴发现场疫苗保护效果评价（SRPG22-009）

2.国家重点研发计划课题：新冠病毒疫苗免疫持久性及加强免疫研究（2021YFC2301602）

3.中国疾病预防控制中心科研项目：新冠病毒灭活疫苗免疫原性及持久性观察（JY21-3-01）

近期成果

1. Tang L, Wang FZ, Rodewald LE, et al. Real-world effectiveness of primary series and booster doses of inactivated COVID-19 vaccine against Omicron BA.2 variant infection in China: a retrospective cohort study. The Journal of infectious diseases 2023.

2. Tang L, Zhang Y, Wang F, et al. Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study. BMJ open 2022; 12(11): e063919.

3. Wu D, Zhang Y, Tang L, et al. Effectiveness of Inactivated COVID-19 Vaccines Against Symptomatic, Pneumonia, and Severe Disease Caused by the Delta Variant: Real World Study and Evidence - China, 2021. China CDC weekly 2022; 4(4): 57-65.

4.唐林,刘倩倩,王晓琪,等.中国扩大国家免疫规划前后不同流行区甲型肝炎报告发病率变化的中断时间序列分析[J].中国疫苗和免疫,2022,01:19-25.